PERIPHERAL T-CELL LYMPHOMA
Clinical trials for PERIPHERAL T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PERIPHERAL T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising lymphoma combo study pulled before starting
Disease control TerminatedThis study was designed to see if adding tazemetostat to standard CHOP chemotherapy could improve outcomes for people with untreated peripheral T cell lymphoma. It was withdrawn before any participants enrolled, so no results are available. The goal was to increase the number of …
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Eric Jacobsen, MD • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
New study aims to find best first treatment for rare blood cancer
Disease control ENROLLING_BY_INVITATIONThis study compares four different chemotherapy combinations as first treatments for peripheral T-cell lymphoma, a rare type of blood cancer. About 114 newly diagnosed patients will receive one of the four regimens to see which works best and has the fewest side effects. The goal…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Engineered immune cells take aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-stage trial tests a new treatment called WU-CART-007 for people with certain blood cancers (like acute myeloid leukemia and T-cell lymphoma) that have not responded to standard therapy. The treatment uses donor immune cells that are specially modified to target and kil…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
Blood test may spot hidden lymphoma clues
Knowledge-focused OngoingThis study looks at whether a blood test can find tiny bits of tumor DNA in people with a rare blood cancer called peripheral T-cell lymphoma. About 45 patients with newly diagnosed or returning lymphoma will give blood samples to check for genetic markers. The goal is to see if …
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC
-
New blood test could revolutionize lymphoma monitoring
Knowledge-focused OngoingThis study looks at whether a new blood test can find tiny bits of tumor DNA in people with T-cell lymphoma. The goal is to see if this test can help doctors track how well treatment is working and watch for signs of the cancer coming back. About 50 adults with newly diagnosed or…
Matched conditions: PERIPHERAL T-CELL LYMPHOMA
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC